Patents by Inventor Saira Sayed Singh

Saira Sayed Singh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of angiogenesis and tumor growth for local and systemic administration
    Patent number: 6696483
    Abstract: The invention provides pharmaceutical formulations and methods for the treatment of individuals suffering from a condition, disease, or disorder that is treatable by the inhibition of angiogenesis. The compositions comprise a Golgi apparatus disturbing agent in a substantially nontoxic amount effective to inhibit angiogenesis in a patient in need of anti-angiogenesis therapy, a solvent, and a pharmaceutically acceptable carrier. In preferred formulations, the Golgi apparatus disturbing agent is brefeldin A.
    Type: Grant
    Filed: October 3, 2001
    Date of Patent: February 24, 2004
    Assignee: OncoPharmaceutical, Inc.
    Inventor: Saira Sayed Singh
  • Treatment of oncologic tumors with an injectable formulation of a golgi apparatus disturbing agent
    Patent number: 6497904
    Abstract: Novel pharmaceutical formulations for treating a cellular proliferative disease are provided comprising: a therapeutically effective amount of a Golgi apparatus disturbing agent; a biocompatible carrier; and a solvent. In preferred formulations, the Golgi apparatus disturbing agent is brefeldin A (BFA) and the biocompatible carrier is a polymer such as chitin or chitosan. Methods of treating cellular proliferative diseases using the pharmaceutical formulations are also described.
    Type: Grant
    Filed: July 23, 2001
    Date of Patent: December 24, 2002
    Inventor: Saira Sayed Singh
  • Inhibitors of angiogenesis and tumor growth for local and systemic administration
    Publication number: 20020061303
    Abstract: The invention provides pharmaceutical formulations and methods for the treatment of individuals suffering from a condition, disease, or disorder that is treatable by the inhibition of angiogenesis. The compositions comprise a Golgi apparatus disturbing agent in a substantially nontoxic amount effective to inhibit angiogenesis in a patient in need of anti-angiogenesis therapy, a solvent, and a pharmaceutically acceptable carrier. In preferred formulations, the Golgi apparatus disturbing agent is brefeldin A.
    Type: Application
    Filed: October 3, 2001
    Publication date: May 23, 2002
    Inventor: Saira Sayed Singh
  • Treatment of oncologic tumors with an injectable formulation of a golgi apparatus disturbing agent
    Publication number: 20020012703
    Abstract: Novel pharmaceutical formulations for treating a cellular proliferative disease are provided comprising: a therapeutically effective amount of a Golgi apparatus disturbing agent; a biocompatible carrier; and a solvent. In preferred formulations, the Golgi apparatus disturbing agent is brefeldin A (BFA) and the biocompatible carrier is a polymer such as chitin or chitosan. Methods of treating cellular proliferative diseases using the pharmaceutical formulations are also described.
    Type: Application
    Filed: July 23, 2001
    Publication date: January 31, 2002
    Inventor: Saira Sayed Singh
  • Treatment of oncologic tumors with an injectable formulation of a Golgi apparatus disturbing agent
    Patent number: 6287602
    Abstract: Novel pharmaceutical formulations for treating a cellular proliferative disease are provided comprising: a therapeutically effective amount of a Golgi apparatus disturbing agent; a biocompatible carrier; and a solvent. In preferred formulations, the Golgi apparatus disturbing agent is brefeldin A (BFA) and the biocompatible carrier is a polymer such as chitin or chitosan. Methods of treating cellular proliferative diseases using the pharmaceutical formulations are also described.
    Type: Grant
    Filed: September 15, 1999
    Date of Patent: September 11, 2001
    Assignee: OncoPharmaceutical, Inc.
    Inventor: Saira Sayed Singh